21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
#5102Formulations of guanylate cyclase C agonists and methods of use
#5103CURCUMIN COMBINATION WITH ANTI-TYPE 2 DIABETIC DRUGS FOR PREVENTION AND TREATMENT OF DISEASE SEQUELAE, DRUG-RELATED ADVERSE REACTIONS, AND IMPROVED GLYCEMIC CONTROL
#5104Combination preparation including a corticosteroid and exosomes
#5105DELAYED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#5106Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
#5107INHIBITING STOMACH-ACID RELEASE, REDUCING INFLAMMATION AND PREVENTING AND TREATING CANCER: COMPOSITIONS AND METHODS OF USE
#5108Cardiac Compositions
#5109Formulations and methods for treating rhinosinusitis
#5110Process to Obtain a Homeopathic Medicament and Use Thereof
#5111Pharmaceutical compositions containing botulinum neurotoxin
#5112Compounds and compositions as TLR activity modulators
#5113Multi-purpose cosmetic compositions
#5114Compositions and Methods for Inducing Apoptosis in Prostate Cancer Cells
#5115PHARMACEUTICAL FORMULATION CONTAINING IMMUNOGLOBULIN
#5116COMBINATION PREPARATION INCLUDING A CYTOKINE ANTAGONIST AND CORTICOSTEROID
#5117MET INHIBITORS FOR ENHANCING RADIOTHERAPY EFFICACY
#5118Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody
#5119FGFR1 extracellular domain combination therapies for lung cancer
#5120METHOD FOR TREATING BREAST CANCER AND OVARIAN CANCER
#5121Method of treatment using solubilized protein composition obtained from eggshell membrane
#5122SUPPOSITORY FOR RECTAL, VAGINAL OR URETHRAL ADMINISTRATION CONTAINING A PROBIOTIC, AN ANTIBIOTIC AND AN UNSATURATED NON-ESTERIFIED FATTY ACID
#5123METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS BY MODULATION OF MICROGLIAL ACTIVATION
#51242′allene-substituted nucleoside derivatives
#5125Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
#5126Modulators of pharmacokinetic properties of therapeutics
#5127Inhibitors
#5128Compositions And Methods For Cell Based Retinal Therapies
#5129METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES USING IMMUNOMODULATORY AGENTS
#5130ORAL COMPOSITIONS CONTAINING EXTRACTS OF GARCINIA MANGOSTANA L. AND RELATED METHODS
#5131ORAL COMPOSITIONS CONTAINING EXTRACTS OF ZIZYPHUS JOAZEIRO AND RELATED METHODS
#5132Stabilization of radiopharmaceutical compositions using ascorbic acid
#5133ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY
#5134Amphiphilic nucleotide cochleate compositions and methods of using the same
#5135USE OF LUTEIN CONTAINING COMPOSITIONS TO IMPROVE CERTAIN ASPECTS OF MEMORY
#5136Methods and compositions for treating depression using cyclobenzaprine
#5137METHODS OF TREATING HYPERACIDIC DISORDERS
#5138Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
#5139Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy
#5140PHARMACEUTICAL COMBINATION OF PROSTAGLANDIN COMPOUND AND NSAID FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
#5141COMBINATION CANCER THERAPY WITH BIS(THIOHYDRAZIDE) AMIDE COMPOUNDS
#5142Multiantivirus compound, composition and method for treatment of virus diseases
#5143NON-PEPTIDE ANTAGONISTS OF GASTRIN RELEASING PEPTIDE
#5144Treatment for discoid lupus
#5145Method of treating an anxiety disorder
#5146METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES
#5147FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF
#5148COMPOSITIONS FOR REDUCING RISK OF ADVERSE EVENTS CAUSED BY DRUG-DRUG INTERACTIONS
#5149Pyrrolotriazine compounds
#5150Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
#5151LUBIPROSTONE FOR OBSTETRICAL OR GYNECOLOGICAL APPLICATIONS
#5152Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia
#5153MEDICATION FOR CLINICAL EXTENSIVELY-DRUG RESISTANT ACINETOBACTER BAUMANNII
#5154Treatment of obesity, metabolic syndrome, and diabetes with protein kinase C inhibitors
#5155INJECTABLE FORMULATIONS FOR INTRA-ARTICULAR OR PERI-ARTICULAR ADMINISTRATION
#5156SAFENER DRUG COMBINATIONS FOR USE WITH NMDA ANTAGONIST DRUGS
#5157Methods for treatment of insulin-like growth factor-1 deficiency
#5158COMPOSITIONS AND METHODS FOR DIABETES TREATMENT
#5159Chimeric adenoviruses for use in cancer treatment
#5160VIRUS-INACTIVATING AGENT
#5161Weight loss composition
#5162MEDICINAL COMPOSITION AND USAGE
#5163Composition and method of treating lipid encapsulated virus infections
#5164Agents derived from Holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases
#5165Combination Therapy for Bipolar Disorder
#5166Method for inducing differentiation of dental pulp cells into odontoblasts
#5167Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
#5168Methods and compositions for controlled delivery of phytochemical agents
#5169ABUSE-RESISTANT OPIOID DOSAGE FORM
#5170Virucidal properties of various forms of sophorolipids
#5171METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#5172Treatment and prevention of dental pathology in humans and non-human animals
#5173Use of an oleogel containing triterpene for healing wounds
#5174Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
#5175COMPOSITION FOR IMPROVING LACTATION
#5176GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT
#5177METHODS AND COMPOUNDS FOR ENHANCING ANTI-CANCER THERAPY
#5178Antibody targeting osteoclast-related protein siglec-15
#5179Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione
#5180Flowable collagen-based hemostat and methods of use
#5181ALKALINE ALPHA GALACTOSIDASE FOR THE TREATMENT OF FABRY DISEASE
#5182LACTASE PREPARATION
#5183Kit for treating a wound
#5184Oncolytic vaccinia virus combination cancer therapy
#5185ANTIVIRAL COMPOUNDS
#5186Compositions and Methods for Soft Tissue Augmentation
#5187Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders
#5188Conditioned cell culture medium compositions and methods of use
#5189Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
#5190Method for cosmetically treating caspase-14 deficiency
#5191Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
#5192Parenteral Administration of Tapentadol
#5193RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT
#5194Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
#5195Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions
#5196Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
#5197Compositions and methods for non-surgical treatment of ptosis
#5198Compositions and methods for non-surgical treatment of ptosis
#5199Compositions and Methods for Non-Surgical Treatment of Ptosis
#5200Treatment of sunburn using analgesics and antihistamines
#5201Replenishing body stores of fat-soluble vitamins A, and D eradicate chronic viral infection
#5202New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives
#5203DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
#5204N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS
#5205COMBINATION OF AN ANTIPSYCHOTIC AND AN ANTI-INFLAMMATORY AGENT
#5206Inhibitors of human immunodeficiency virus replication
#5207HORMONE REPLACEMENT THERAPY AND DEPRESSION
#5208HYDROXYTYROSOL COMBINATIONS FOR ENHANCING MITOCHONDRIAL FUNCTION AND ENERGY PRODUCTION
#5209Anti-tumor effect potentiator
#5210Compositions comprising decitabine and tetrahydrouridine and uses thereof
#5211Composition for treating mental health disorders
#5212CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
#5213Methods for treating radiation burns
#5214Human placental collagen compositions, and methods of making and using the same
#5215Topical skin care formulations
#5216COMPOSITION FOR ALLEVIATING FATTY LIVER
#5217Herbal Supplement Prepared From Geranium
#5218COLD SORE FORMULATION AND RELATED METHOD OF MANUFACTURE
#5219Herbal Supplement Prepared From Pelargonium Citronellum
#5220Substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins
#5221COMPOSITION FOR COUNTERACTING SMOKING TOXICITY
#5222Method and composition for improved anabolism
#5223PROCESS UTILIZING A COMBINATION OF AN ACID BLEND, PECTIC ENZYME AND YEAST IN A WINE FERMENTATION CONTAINER TO EXTRACT THE BIOLOGICALLY ACTIVE COMPOUNDS FROM MEDICINAL HERBS
#5224Antimicrobial and antiviral composition
#5225Methods and compositions for the treatment and prevention Hypoglycemia and related disorders
#5226Use of an agent that restores tissue perfusion and oxygenation
#5227Use of Synergistic Combinations of an Avermectin and an Antineoplastic Compounds for the Treatment of Hematological Malignancies
#5228Bioequivalent formulation of efavirenz
#5229THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS
#5230Methods and compositions for improved deliver, expression or activity of RNA interference agents
#5231Abrogating HIV-1 Infection via Drug-Induced Reactivation of Apoptosis
#5232METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
#5233Sphingosine 1-Phosphate Antagonism
#5234TREATMENT RESPONSE TO ANTI-ANGIOGENIC THERAPIES
#5235TETRASUBSTITUTED CYCLOHEXYL COMPOUNDS AS KINASE INHIBITORS
#5236COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CONDITIONS ASSOCIATED WITH INFLAMATION
#5237Kits for treating wounds
#5238SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#5239Skin cream
#5240COMPOSITIONS AND METHODS FOR MOBILIZATION OF STEM CELLS
#5241Ophthalmic Solutions
#5242TRI-AMINO RELEASING FULVATE
#5243USE OF METHYLSULFONYLMETHANE (MSM) TO INHIBIT MICROBIAL ACTIVITY
#5244USE OF METFORMIN IN CANCER TREATMENT AND PREVENTION
#5245PHYTOCEUTICAL COMPOSITIONS FOR PETS
#5246Synergistic anti-inflammatory and antioxidant dietary supplement compositions
#5247Synthetic triterpenoids and methods of use in the treatment of disease
#5248Desferrioxamine-metal complexes for the treatment of immune-related disorders
#5249Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
#5250Laser enhanced amino acid blend and use of same to regenerate active myocardial tissue
#5251Ophthalmologic compositions and use mode thereof
#5252Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases
#5253Methods for treatment of Fabry disease
#5254Method for determining sensitivity to an anticancer agent
#5255Oxopiperazine derivatives for the treatment of pain and epilepsy
#5256Delta opioid receptor agonist compounds
#5257Substituted quinoxaline carboxylic acid compounds for the inhibition of PASK
#5258LIQUID PROPELLANT-FREE FORMULATION COMPRISING AN ANTIMUSCARINIC DRUG
#5259DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#5260COMPOSTIONS DESIGNED FOR THE INHIBITION AND/OR BLOCKING OF THE EPITHELIAL/MESENCHYMAL TRANSITION
#5261Coumarin compounds as melanogenesis modifiers and uses thereof
#5262Treatment of Glaucoma and Other Retinopathies with Gangliosides
#5263Lunasin-containing complex and purification of lunasin from plants
#5264Cyclic-GluR6 analogs, methods of treatment and use
#5265Modulating neuromuscular junction density changes in botulinum-toxin treated tissue
#5266SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY
#5267Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#5268BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT
#5269NGAL FOR DIAGNOSIS OF RENAL CONDITIONS
#5270ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH
#5271Colon cleansing of residual stool and secretions during colonoscopy
#5272NUTRITIONAL SUPPLEMENT FOR PATIENTS WITH CHRONIC HEART FAILURE
#5273Treatment of urinary incontinence using nitrone spin traps
#5274Compositions and soft tissue replacement methods
#5275PHARMACEUTICAL COMPOSITIONS COMPRISING BI-1356 AND METFORMIN
#5276Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
#5277SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS IN HUMANS
#5278LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
#5279Therapeutic Use of a TLR Agonist and Combination Therapy
#5280Composition comprising biodegradable hydrating ceramics for controlled drug delivery
#5281Adjuvanted vaccine formulations
#5282Methods and formulations for treating chronic liver disease
#5283EPIDITHIODIOXOPIPRAZINES AND USES THEREOF IN TREATING CANCER
#5284Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
#5285Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#5286PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR
#5287Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor
#5288Therapeutic Compositions Comprising Monoterpenes
#5289Method for repairing DNA damage in keratinocytes
#5290NUTRITIONAL COMPOSITIONS COMPRISING LACTOFERRIN AND PROBIOTICS AND KITS OF PARTS THEREOF
#5291Method of treating tuberculosis with interferons
#5292Substituted quinoline compounds and methods of use
#5293Dermal delivery device
#5294Stable rasagiline composition
#5295Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet
#5296Cysteine for physiological injection
#5297METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME
#5298METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#5299Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
#5300SENSITIZER, PHARMACEUTICAL COMPOSITION, KIT AND USE FOR TARGET THERAPY
#5301Sensitizer, kit and use for cancer therapy
#5302IMMUNE ENHANCEMENT COMPOSITION AND KIT AND USE THEREOF
#5303Inhibitors of Bruton's tyrosine kinase
#5304mTOR/JAK inhibitor combination therapy
#5305Use of N--4-(3-pyridyl)-2-pyridine-amine for the Treatment of Pulmonary Hypertension
#5306Aminoindane compounds and use thereof in treating pain
#5307Antibacterial food composition
#5308FULVESTRANT IN A DOSAGE OF 500mg FOR THE TREATMENT OF ADVANCED BREAST CANCER
#5309Treatment of solid tumors with rapamycin derivatives
#5310Compositions for treatment of inflammatory diseases
#5311METHOD AND KIT FOR GASTRO-INTESTINAL CLEANSING
#5312PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE
#5313Methods and compositions for treating cancer using proteasome inhibitors
#5314METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES
#5315PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#5316METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#5317Acetamide derivatives as glucokinase activators, their process and medicinal applications
#5318HERBAL SOLID FORMULATION AND PROCESS FOR PREPARING THE SAME
#5319Miracle cream
#5320COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF
#5321HERBAL SOLID FORMULATION AND PROCESS FOR PREPARING THE SAME
#5322Pain relieving composition
#5323Negative Ion-Releasing Silica Compositions and Methods of Preparing and Using the Same
#5324Compositions and soft tissue replacement methods
#5325Compositions and soft tissue replacement methods
#5326Solid pharmaceutical compositions containing an integrase inhibitor
#5327Microporous zirconium silicate for the treatment of hyperkalemia
#5328Compositions Comprising Peroxy alpha-Ketocarboxylic Acid and Methods For Producing and Using the Same
#5329Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#5330CHEMO-IMMUNOTHERAPY METHOD
#5331COMBINATION THERAPY FOR IMMUNOSTIMULATION
#5332bacterin vaccine
#5333ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
#5334METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES
#5335Method for the potentiation of opioid analgesics effects on pain
#5336ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF
#5337Anticancer Compounds from Vernonia Guineensis
#5338NOVEL METHOD FOR THE PRODUCTION OF A ANTIMICROBIAL PEPTIDE
#5339NUTRACEUTICAL BEVERAGE
#5340SEMI-SYNTHETIC PLATELET GEL AND METHOD FOR THE PREPARATION THEREOF
#5341Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
#5342THERAPEUTIC FUROPYRIMIDINES AND THIENOPYRIMIDINES
#5343Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma
#5344Methods and compositions for treating autoimmune diseases
#5345Compounds for the treatment of hepatitis C
#5346Hydrogel encapsulated cells and anti-inflammatory drugs
#5347Cutter assembly for tunnel boring machine with pressure compensation
#5348Macrocyclic inhibitors of hepatitis C virus replication
#5349NUTRITIONAL COMPOSITIONS FOR MODULATING INFLAMMATION INCLUDING EXOGENOUS VITAMIN K2
#5350Methods for concomitant administration of colchicine and a second active agent
#5351STABLE, LIQUID, READY-TO-USE KETOPROFEN FORMULATIONS
#5352Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#5353TREATMENT OF ONCOLOGICAL DISEASES
#5354Methods for concomitant administration of colchicine and a second active agent
#5355Medical composition
#5356Skin treatment in antiseptic thin film form with silver
#5357TEA POLYPHENOLS PRODUCTS FOR CEASING SMOKING AND TREATING AND/OR PREVENTING NICOTINE OR NICOTINE-DERIVED COMPOUNDS OR ESTROGEN INDUCED BREAST CANCER
#5358USE OF TEA POLYPHENOLS FOR TREATING AND/OR PREVENTING NICOTINE OR NICOTINE-DERIVED COMPOUNDS OR ESTROGEN INDUCED BREAST CANCER
#5359Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
#5360HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE
#5361THERAPEUTIC COMBINATION
#5362Pyrazolopyrimidine derivatives
#5363Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
#5364CRYSTALLINE FORM OF FOSAMPRENAVIR CALCIUM
#5365Modulation of Growth of Bifidobacteria Using a Combination of Oligosaccharides Found in Human Milk
#5366ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH
#5367PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE
#5368Cytokine zalpha11 ligand
#5369Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1
#5370TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING
#5371TREATMENT OF HIV
#5372ORAL INHIBITORS OF AGE-RELATED NADH OXIDASE (arNOX), COMPOSITIONS AND NATURAL SOURCES
#5373CEPHALOTAXINE ALKALOID COMPOSITIONS AND USES THEREOF
#5374Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#5375Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#5376Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
#5377Compositions and methods for treating extracellular parasitic infections
#5378Treatment of cardiovascular disease and thrombosis
#5379Method and system for effecting changes in pigmented tissue
#5380Transfer Resistant Cosmetic
#5381Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
#5382CATIONIC POLYMER COATED MESOPOROUS SILICA NANOPARTICLES AND USES THEREOF
#5383TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING
#5384Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
#5385T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy
#5386Composition to Induce Specific Immune Tolerance
#5387Enzymes For Pharmaceutical Use
#5388Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger
#5389Methods and Compositions for Treating Viral Hemorrhagic Fever
#5390Epithelium-improving agent
#5391Autism-associated biomarkers and uses thereof
#5392MESENCHYMAL STEM CELL INCORPORATING A NUCLEOTIDE SEQUENCE CODING TGFB, AND USES THEREOF
#5393INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#5394Nutritional supplement to improve supplementary target protein fraction (TPF) delivery, intracellular absorption and utilization
#5395Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing at a site of treatment
#5396Rosacea Topical Skin Treatment Method and Formulation
#5397TOPICAL FORMULATIONS OF TARGETED NITROXIDE AGENTS
#5398Non-ozone depleting medicinal formulations with low greenhouse effect
#5399COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS
#5400ALLOGRAFT BONE COMPOSITION HAVING A GELATIN BINDER